These medications work by mimicking the action of the naturally occurring GLP-1 hormone, which stimulates insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite
The SHAPE study: real-world evidence The SHAPE study, published in 2025, examined real-world weight loss in patients with overweight or obesity who did not have type 2 diabetes
To make the medication more affordable, Eli Lilly is actively collaborating with insurers
Maintain a Healthy Lifestyle : Pairing injections with a balanced diet and regular exercise can enhance results and minimize side effects
Berberine is an unlicensed supplement with modest effects and limited evidence, whilst GLP-1 receptor agonists are rigorously tested, MHRA-licensed medicines with proven efficacy for type 2 diabetes management under medical supervision
The presentation can vary considerably, with some individuals experiencing subtle symptoms whilst others develop dramatic, life-threatening manifestations
